|
US6008202A
(en)
*
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5795587A
(en)
*
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
JP2001510457A
(ja)
*
|
1996-11-12 |
2001-07-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インビボ送達に有効な、脂質―核酸複合体の安定な製剤の調製
|
|
US6210707B1
(en)
*
|
1996-11-12 |
2001-04-03 |
The Regents Of The University Of California |
Methods of forming protein-linked lipidic microparticles, and compositions thereof
|
|
JP2000514094A
(ja)
*
|
1997-04-17 |
2000-10-24 |
レオネ，パオラ |
脳への遺伝子治療のための送達システム
|
|
US6749863B1
(en)
|
1997-11-19 |
2004-06-15 |
Georgetown University |
Targeted liposome gene delivery
|
|
WO2000003683A2
(en)
*
|
1998-07-20 |
2000-01-27 |
Inex Pharmaceuticals Corporation |
Liposomal encapsulated nucleic acid-complexes
|
|
US7780882B2
(en)
|
1999-02-22 |
2010-08-24 |
Georgetown University |
Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
|
|
US9034330B2
(en)
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
PT1811036E
(pt)
*
|
1999-02-22 |
2011-07-11 |
Univ Georgetown |
Imunolipossomas dirigidos por fragmento de anticorpo para distribuição sistémica de genes
|
|
US9034329B2
(en)
|
1999-02-22 |
2015-05-19 |
Georgetown University |
Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
|
|
PL351487A1
(en)
*
|
1999-03-02 |
2003-04-22 |
Liposome Co Inc |
Encapsulation of bioactive complexes in liposomes
|
|
EP1754488A1
(en)
*
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
AU5161800A
(en)
*
|
1999-05-24 |
2000-12-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
US7067111B1
(en)
*
|
1999-10-25 |
2006-06-27 |
Board Of Regents, University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
US7189705B2
(en)
*
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
|
US10293056B1
(en)
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
JP5448284B2
(ja)
|
2000-06-02 |
2014-03-19 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
エチレンジシステイン（ｅｃ）−薬物結合体
|
|
AU2001294890A1
(en)
*
|
2000-09-25 |
2002-04-02 |
Board Of Regents, The University Of Texas System |
Pei: dna vector formulations for in vitro and in vivo gene delivery
|
|
US20020146829A1
(en)
*
|
2000-11-29 |
2002-10-10 |
Aventis Pharmaceuticals Products Inc. |
Neutral and anionic colloidal particles for gene delivery
|
|
DE60228842D1
(de)
*
|
2001-04-02 |
2008-10-23 |
Univ Georgetown |
Vereinfachtes und verbessertes verfahren zur herstellung eines antikörper- oder antikörperfragment-targeted immunoliposoms oder polyplex für die systemische verabreichung eines therapeutischen oder diagnostischen mittels
|
|
EP1389090A2
(en)
*
|
2001-04-26 |
2004-02-18 |
Board of Regents, The University of Texas System |
Diagnostic imaging compositions, their methods of synthesis and use
|
|
WO2002088318A2
(en)
*
|
2001-04-30 |
2002-11-07 |
Targeted Genetics Corporation |
Lipid-comprising drug delivery complexes and methods for their production
|
|
CA2447548A1
(en)
*
|
2001-05-15 |
2002-11-21 |
Transgene S.A. |
Complexes for transferring substances of interest into a cell
|
|
FR2829136B1
(fr)
*
|
2001-08-29 |
2006-11-17 |
Aventis Pharma Sa |
Derives lipidiques d'aminoglycosides
|
|
US20030049203A1
(en)
*
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
|
US7261875B2
(en)
*
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
|
KR100466254B1
(ko)
*
|
2002-02-25 |
2005-01-14 |
한국과학기술원 |
세포내 전달을 위한 올리고뉴클레오티드와 친수성 고분자로 구성되는 유전자 전달용 접합체, 고분자 전해질 복합 미셀 및 그의 제조방법
|
|
AU2003237864B2
(en)
*
|
2002-05-15 |
2008-12-18 |
California Pacific Medical Center |
Delivery of nucleic acid-like compounds
|
|
US20040137064A1
(en)
*
|
2003-01-15 |
2004-07-15 |
Lewis David L. |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
|
EP1513538A4
(en)
*
|
2002-06-14 |
2007-08-22 |
Mirus Bio Corp |
Novel methods for introducing polynucleotides into cells
|
|
WO2004044227A2
(en)
*
|
2002-11-07 |
2004-05-27 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
|
|
EP1587923B1
(en)
|
2003-01-22 |
2011-08-24 |
Duke University |
Improved constructs for expressing lysosomal polypeptides
|
|
WO2005037858A2
(en)
*
|
2003-10-16 |
2005-04-28 |
University Of Massachusetts |
Template-directed assembly of receptor signaling complexes
|
|
US9050378B2
(en)
*
|
2003-12-10 |
2015-06-09 |
Board Of Regents, The University Of Texas System |
N2S2 chelate-targeting ligand conjugates
|
|
US20050261221A1
(en)
*
|
2004-03-01 |
2005-11-24 |
Li Wang |
Compositions and methods for enhanced delivery of compounds via transfection complexes
|
|
JP2007532573A
(ja)
*
|
2004-04-09 |
2007-11-15 |
バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド |
ヌクレオチド−渦巻状組成物および使用の方法
|
|
US20090005332A1
(en)
*
|
2004-12-30 |
2009-01-01 |
Hauser Todd M |
Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides
|
|
CN101111269A
(zh)
*
|
2005-01-28 |
2008-01-23 |
协和发酵工业株式会社 |
抑制靶基因表达的组合物
|
|
EP1970078A4
(en)
*
|
2006-01-11 |
2010-11-17 |
Kyowa Hakko Kirin Co Ltd |
COMPOSITION INHIBITING THE EXPRESSION OF A TARGET GENE OF THE OCULAR GLOBE AND REMEDY FOR OCULAR GLOBE DISEASE
|
|
WO2007112107A2
(en)
*
|
2006-03-24 |
2007-10-04 |
Gencia Corporation |
Synthetic lipid rafts and methods of use
|
|
US8758723B2
(en)
|
2006-04-19 |
2014-06-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for cellular imaging and therapy
|
|
PT2019683T
(pt)
|
2006-04-25 |
2017-03-17 |
Univ California |
Administração de fatores de crescimento para o tratamento de distúrbios do snc
|
|
US20070259031A1
(en)
*
|
2006-04-26 |
2007-11-08 |
The Regents Of The University Of California |
Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
|
|
WO2008002656A2
(en)
*
|
2006-06-28 |
2008-01-03 |
P.A. Technologies Llc |
Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
|
|
US20080213349A1
(en)
*
|
2006-09-11 |
2008-09-04 |
Deepak Ramesh Thakker |
Liposome Complexes Containing Pharmaceutical Agents and Methods
|
|
WO2008040792A2
(en)
*
|
2006-10-04 |
2008-04-10 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
|
|
US10925977B2
(en)
*
|
2006-10-05 |
2021-02-23 |
Ceil>Point, LLC |
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
|
|
WO2008116347A1
(en)
|
2007-03-26 |
2008-10-02 |
General Regeneratives Limited |
Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
|
|
EP2175835B1
(en)
*
|
2007-07-09 |
2016-04-20 |
Georgetown University |
Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
|
|
CN102065901B
(zh)
*
|
2008-06-19 |
2013-03-06 |
日本新药株式会社 |
药物载体
|
|
AU2009330859B2
(en)
*
|
2008-12-26 |
2013-06-20 |
Samyang Holdings Corporation |
Pharmaceutical composition containing an anionic drug, and a production method therefor
|
|
TWI540319B
(zh)
|
2010-03-29 |
2016-07-01 |
中央研究院 |
以細胞質譜分析定量細胞所攝入之奈米/微米粒子
|
|
RU2436583C1
(ru)
*
|
2010-07-06 |
2011-12-20 |
Общество с ограниченной ответственностью "ВИТАЛАНГ" |
Противовирусное средство
|
|
JP5760562B2
(ja)
*
|
2011-03-22 |
2015-08-12 |
セイコーエプソン株式会社 |
読取装置および読取方法
|
|
PL2760463T3
(pl)
|
2011-09-20 |
2019-05-31 |
Univ North Carolina Chapel Hill |
Regulacja kanałów sodowych przez białka PLUNC
|
|
US9238865B2
(en)
|
2012-02-06 |
2016-01-19 |
Asm Ip Holding B.V. |
Multiple vapor sources for vapor deposition
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
EP3405576A4
(en)
|
2016-01-19 |
2019-09-18 |
The University of North Carolina at Chapel Hill |
METHOD AND COMPOSITIONS WITH RNA INTERFERENCE FOR KRAS INHIBITION
|
|
BR112018017144A2
(pt)
|
2016-02-22 |
2019-01-15 |
Univ North Carolina Chapel Hill |
inibidores de peptídeo de canais de cálcio
|
|
US11788190B2
(en)
|
2019-07-05 |
2023-10-17 |
Asm Ip Holding B.V. |
Liquid vaporizer
|
|
JP2022540819A
(ja)
*
|
2019-07-10 |
2022-09-20 |
ユニバーシティ オブ ワシントン |
非ウイルス性免疫標的化
|
|
US11946136B2
(en)
|
2019-09-20 |
2024-04-02 |
Asm Ip Holding B.V. |
Semiconductor processing device
|
|
GB202004254D0
(en)
|
2020-03-24 |
2020-05-06 |
Puridify Ltd |
Characterization of gene therapy vectors
|
|
JPWO2023054243A1
(enExample)
*
|
2021-09-30 |
2023-04-06 |
|
|
|
DE102023001946A1
(de)
*
|
2023-05-12 |
2024-11-14 |
Friedrich-Schiller-Universität Jena, Körperschaft des öffentlichen Rechts |
Nanopartikel für den Transport von Wirkstoffen mit anionischen Gruppen, Verfahren zu deren Herstellung und deren Verwendung
|
|
CN119490670A
(zh)
*
|
2024-11-26 |
2025-02-21 |
山东大学 |
一种慢病毒转染增强纳米颗粒及其制备方法与应用
|